Literature DB >> 11988639

Metabolic abnormalities in the diabetic heart.

Gary D Lopaschuk1.   

Abstract

Congestive heart failure is a major health problem in the diabetic. Diabetics have a high incidence of heart disease, including an increased incidence and severity of congestive heart failure than the non-diabetic. Progression to heart failure after an acute myocardial infarction is also more frequent in diabetics then non-diabetics. While atherosclerosis and ischemic injury are important contributing factors to this high in incidence of heart failure, another important factor is diabetes-induced changes within the heart itself. A prominent change that occurs in the diabetic is a switch in cardiac energy metabolism. Increases in fatty acid oxidation accompanied by decreases in glucose metabolism can result in the myocardium becoming almost entirely reliant on fatty acid oxidation as a source of energy. This switch in energy metabolism contributes to congestive heart failure by increasing the severity of injury following an acute myocardial infarction, and by having direct negative effects on contractile function. This paper will review the evidence linking alterations in energy metabolism to alterations in contractile function in the diabetic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988639     DOI: 10.1023/a:1015328625394

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  88 in total

1.  Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart.

Authors:  J Sakamoto; R L Barr; K M Kavanagh; G D Lopaschuk
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-04       Impact factor: 4.733

2.  Acute myocardial infarction in 258 cases of diabetes. Immediate mortality and five-year survival.

Authors:  J O Partamian; R F Bradley
Journal:  N Engl J Med       Date:  1965-08-26       Impact factor: 91.245

3.  Clinical and morphological features of human hypertensive-diabetic cardiomyopathy.

Authors:  S M Factor; T Minase; E H Sonnenblick
Journal:  Am Heart J       Date:  1980-04       Impact factor: 4.749

4.  Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.

Authors:  J R Dyck; L G Berthiaume; P D Thomas; P F Kantor; A J Barr; R Barr; D Singh; T A Hopkins; N Voilley; M Prentki; G D Lopaschuk
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

5.  Effect of choline and methionine treatment on cardiac dysfunction of diabetic rats.

Authors:  C E Heyliger; B Rodrigues; J H McNeill
Journal:  Diabetes       Date:  1986-10       Impact factor: 9.461

6.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.

Authors:  P H Stone; J E Muller; T Hartwell; B J York; J D Rutherford; C B Parker; Z G Turi; H W Strauss; J T Willerson; T Robertson
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

7.  Effects of free fatty acids and dichloroacetate on isolated working diabetic rat heart.

Authors:  T A Nicholl; G D Lopaschuk; J H McNeill
Journal:  Am J Physiol       Date:  1991-10

8.  Performance of diabetic rat hearts: effects of anoxia and increased work.

Authors:  C G Ingebretsen; P Moreau; C Hawelu-Johnson; W R Ingebretsen
Journal:  Am J Physiol       Date:  1980-11

9.  Acute myocardial infarction in dogs with experimental diabetes.

Authors:  R Forrat; L Sebbag; N Wiernsperger; J Guidollet; S Renaud; M de Lorgeril
Journal:  Cardiovasc Res       Date:  1993-11       Impact factor: 10.787

10.  Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy).

Authors:  A Vered; A Battler; P Segal; D Liberman; Y Yerushalmi; M Berezin; H N Neufeld
Journal:  Am J Cardiol       Date:  1984-09-01       Impact factor: 2.778

View more
  48 in total

1.  Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study.

Authors:  Brendan M Everett; Nancy R Cook; Maria C Magnone; Maria Bobadilla; Eunjung Kim; Nader Rifai; Paul M Ridker; Aruna D Pradhan
Journal:  Circulation       Date:  2011-05-31       Impact factor: 29.690

2.  Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Authors:  Pavan K Battiprolu; Thomas G Gillette; Zhao V Wang; Sergio Lavandero; Joseph A Hill
Journal:  Drug Discov Today Dis Mech       Date:  2010

3.  Differential expression of lipid and carbohydrate metabolism genes in upper airway versus diaphragm muscle.

Authors:  Erik van Lunteren; Sarah Spiegler; Michelle Moyer
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

4.  Kinetics of fatty acid binding ability of glycated human serum albumin.

Authors:  Eiji Yamazaki; Minoru Inagaki; Osamu Kurita; Tetsuji Inoue
Journal:  J Biosci       Date:  2005-09       Impact factor: 1.826

5.  Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.

Authors:  L N Axelsen; W Keung; H D Pedersen; E Meier; D Riber; A L Kjølbye; J S Petersen; S D Proctor; N-H Holstein-Rathlou; G D Lopaschuk
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 6.  Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

Authors:  Rokhsana Mortuza; Subrata Chakrabarti
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 7.  Epicardial adipose tissue: far more than a fat depot.

Authors:  Andrew H Talman; Peter J Psaltis; James D Cameron; Ian T Meredith; Sujith K Seneviratne; Dennis T L Wong
Journal:  Cardiovasc Diagn Ther       Date:  2014-12

8.  The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction.

Authors:  Jeanna C Perman; Pontus Boström; Malin Lindbom; Ulf Lidberg; Marcus StÅhlman; Daniel Hägg; Henrik Lindskog; Margareta Scharin Täng; Elmir Omerovic; Lillemor Mattsson Hultén; Anders Jeppsson; Petur Petursson; Johan Herlitz; Gunilla Olivecrona; Dudley K Strickland; Kim Ekroos; Sven-Olof Olofsson; Jan Borén
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

9.  Acetyl L-carnitine targets adenosine triphosphate synthase in protecting zebrafish embryos from toxicities induced by verapamil and ketamine: An in vivo assessment.

Authors:  Xiaoqing Guo; Melanie Dumas; Bonnie L Robinson; Syed F Ali; Merle G Paule; Qiang Gu; Jyotshna Kanungo
Journal:  J Appl Toxicol       Date:  2016-05-18       Impact factor: 3.446

10.  Gene expression profiling in the type 1 diabetes rat diaphragm.

Authors:  Erik van Lunteren; Michelle Moyer
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.